Randomly comparative study on the therapeutic effects of Fufangkushen injection and Aidi injection on improving quality of life for patients with advanced lung cancer / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 153-156, 2012.
Artículo
en Chino
| WPRIM
| ID: wpr-428637
ABSTRACT
Objective To explore and compare the therapeutic effects of Fufangkushen injection and Aidi injection on improving quality of life for patients with advanced lung cancer. Methods 60 patients in late stage of lung cancer with pathological diagnosis were split into two groups randomly. 30 patients in Kushen group received Fufangkushen injection plus base therapy, 30 patients in Aidi group received Aidi injection plus base therapy.The data was analyzed on term of tumour size,clinical symptoms,Karnofsky score,cancer marker CA125,CEA,before and after treatment in two groups.The therapeutic effects were evaluated after two circles of treatment. Results Compared the short term therapeutic effect, Kushen group had the stability rate for 83.3 %(25/30),and 80.0 %(24/30) for Aidi group.There was no significant difference.(P>0.05).Compare the clinical therapeutic effect,Kushen group had the improving rate for 83.3 %(25/30),and 80.0 %(24/30) for Aidi group.There was no significant difference(P>0.05).Compare the Karnofsky score,two groups had equal increasing stability rate (P>0.05). Compare decreasing ratio of CEA and CA125 after treatment in two groups,there was no significant difference (P>0.05). Conclusion Fufangkushen injection and Aidi injection both have acceptable therapeutic effects in the treatment of patients with later stage lung cancer.The result is equal. As well as they have some other characters themselves to improve lung cancer related symptoms. Fufangkushen injection is better to improve symptoms of heat toxin, and Aidi injection is better to improve symtoms of deficiency Qi. For Fufangkushen injection, it can also adjust disorder of liver function and relieve pain.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Chino
Revista:
Cancer Research and Clinic
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS